Integer Holdings Co. (NYSE:ITGR) Receives Consensus Rating of "Buy" from Brokerages

Shares of Integer Holdings Co. (NYSE:ITGR - Get Free Report) have been assigned a consensus recommendation of "Buy" from the nine ratings firms that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation, seven have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $145.00.

ITGR has been the topic of a number of recent analyst reports. Raymond James lifted their price target on Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a report on Friday, April 25th. Benchmark dropped their price target on Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a report on Friday, April 25th. Oppenheimer lowered Integer from an "outperform" rating to a "market perform" rating in a report on Friday, February 21st. Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and lifted their price target for the stock from $133.00 to $140.00 in a report on Thursday, May 22nd. Finally, KeyCorp dropped their price target on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a report on Monday, April 21st.

Integer Stock Up 2.8%

Shares of NYSE ITGR traded up $3.33 during midday trading on Monday, hitting $121.64. 399,696 shares of the stock traded hands, compared to its average volume of 373,023. The company has a market cap of $4.24 billion, a PE ratio of 36.20, a P/E/G ratio of 1.72 and a beta of 1.03. The business has a 50 day moving average price of $118.35 and a two-hundred day moving average price of $129.00. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. Integer has a one year low of $104.93 and a one year high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. The firm had revenue of $437.39 million during the quarter, compared to the consensus estimate of $428.51 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. The company's quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the prior year, the business posted $1.14 earnings per share. On average, equities analysts predict that Integer will post 6.01 EPS for the current year.

Insider Buying and Selling at Integer

In related news, CEO Joseph W. Dziedzic sold 338,975 shares of the business's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the sale, the chief executive officer now directly owns 47,000 shares in the company, valued at approximately $5,788,990. The trade was a 87.82% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 2.16% of the company's stock.

Institutional Trading of Integer

A number of hedge funds and other institutional investors have recently made changes to their positions in ITGR. Janney Montgomery Scott LLC raised its stake in shares of Integer by 2.0% during the 4th quarter. Janney Montgomery Scott LLC now owns 9,865 shares of the medical equipment provider's stock valued at $1,307,000 after purchasing an additional 197 shares during the period. Exchange Traded Concepts LLC increased its stake in Integer by 2.6% in the 4th quarter. Exchange Traded Concepts LLC now owns 5,800 shares of the medical equipment provider's stock worth $769,000 after acquiring an additional 145 shares during the last quarter. Blue Trust Inc. increased its stake in Integer by 4.4% in the 4th quarter. Blue Trust Inc. now owns 1,689 shares of the medical equipment provider's stock worth $220,000 after acquiring an additional 71 shares during the last quarter. KBC Group NV increased its stake in Integer by 83.3% in the 4th quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider's stock worth $212,000 after acquiring an additional 726 shares during the last quarter. Finally, R Squared Ltd bought a new position in Integer in the 4th quarter worth about $44,000. 99.29% of the stock is currently owned by institutional investors.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.